Correction: Four-in-One Antibodies Have Superior Cancer Inhibitory Activity against EGFR, HER2, HER3, and VEGF through Disruption of HER/MET Crosstalk

Cancer Res. 2019 Jul 1;79(13):3525. doi: 10.1158/0008-5472.CAN-19-1515.
No abstract available

Publication types

  • Published Erratum